Connection
David Kroll to Leukemia
This is a "connection" page, showing publications David Kroll has written about Leukemia.
|
|
Connection Strength |
|
 |
|
 |
|
0.079 |
|
|
|
-
Kurz EU, Wilson SE, Leader KB, Sampey BP, Allan WP, Yalowich JC, Kroll DJ. The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines. Mol Cancer Ther. 2001 Dec; 1(2):121-31.
Score: 0.040
-
Baker RK, Kurz EU, Pyatt DW, Irons RD, Kroll DJ. Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIalpha. Blood. 2001 Aug 01; 98(3):830-3.
Score: 0.039